Literature DB >> 27845158

The application of nanoparticles in diagnosis and theranostics of gastric cancer.

Rutian Li1, Baorui Liu2, Jiahui Gao1.   

Abstract

Gastric cancer is the fourth most common cancer and the second leading cause of cancer related death worldwide. For the diagnosis of gastric cancer, apart from regular systemic imaging, the locoregional imaging is also of great importance. Moreover, there are still other ways for the detecting of gastric cancer, including the early detection of gastric cancer by endoscopy, the detection of gastric-cancer related biomarkers and the detection of circulating tumor cells (CTCs) of gastric cancer. However, conventional diagnostic methods are usually lack of specificity and sensitivity. Nanoparticles provide many benefits in the diagnosis of gastric cancer. Besides, nanoparticles are capable of integrating the functions of diagnosis and treatment together (theranostics). In this paper, we reviewed the applications of nanoparticles in diagnosis and theranostics of gastric cancer in the above mentioned aspects.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diagnosis; Gastric cancer; Nanoparticles; Theranostics

Mesh:

Substances:

Year:  2016        PMID: 27845158     DOI: 10.1016/j.canlet.2016.10.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Long Non-coding RNA LINC01503 Promotes Gastric Cancer Cell Proliferation and Invasion by Regulating Wnt Signaling.

Authors:  Jian Ding; Feng Shi; Guangdong Xie; Yong Zhu
Journal:  Dig Dis Sci       Date:  2020-03-23       Impact factor: 3.199

Review 2.  Nanoparticles in Gastrooncology.

Authors:  André Jefremow; Markus F Neurath
Journal:  Visc Med       Date:  2020-03-18

3.  lncRNA NEAT1 regulates gastric carcinoma cell proliferation, invasion and apoptosis via the miR‑500a‑3p/XBP‑1 axis.

Authors:  Yun Zhou; Zhenghong Sha; Yong Yang; Shuimei Wu; Hong Chen
Journal:  Mol Med Rep       Date:  2021-05-13       Impact factor: 2.952

Review 4.  Application of electrochemical biosensors in tumor cell detection.

Authors:  Zhenhua Zhang; Qingchao Li; Xin Du; Min Liu
Journal:  Thorac Cancer       Date:  2020-02-26       Impact factor: 3.500

5.  Silencing of Long Non-Coding RNA-HCG18 Inhibits the Tumorigenesis of Gastric Cancer Through Blocking PI3K/Akt Pathway.

Authors:  Fengzhen Ma; Kexiang An; Yuqin Li
Journal:  Onco Targets Ther       Date:  2020-03-18       Impact factor: 4.147

6.  Construction of homologous cancer cell membrane camouflage in a nano-drug delivery system for the treatment of lymphoma.

Authors:  Qiangqiang Zhao; Xiaoying Sun; Bin Wu; Yinghui Shang; Xueyuan Huang; Hang Dong; Haiting Liu; Wansong Chen; Rong Gui; Jian Li
Journal:  J Nanobiotechnology       Date:  2021-01-06       Impact factor: 10.435

7.  Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells.

Authors:  Bianca N Lourenço; Rúben F Pereira; Cristina C Barrias; Claudia Fischbach; Carla Oliveira; Pedro L Granja
Journal:  Nanomaterials (Basel)       Date:  2021-01-23       Impact factor: 5.076

Review 8.  Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies.

Authors:  Zhengyang Yang; Wei Deng; Xiao Zhang; Yongbo An; Yishan Liu; Hongwei Yao; Zhongtao Zhang
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

9.  LncRNA LINC00342 promotes gastric cancer progression by targeting the miR-545-5p/CNPY2 axis.

Authors:  Run Liu; Xianwu Yang
Journal:  BMC Cancer       Date:  2021-10-30       Impact factor: 4.430

10.  Molecular and Cellular Risk Assessment of Healthy Human Cells and Cancer Human Cells Exposed to Nanoparticles.

Authors:  Edward Helal-Neto; Aline Oliveira da Silva de Barros; Roberta Saldanha-Gama; Renata Brandão-Costa; Luciana Magalhães Rebêlo Alencar; Clenilton Costa Dos Santos; Ramón Martínez-Máñez; Eduardo Ricci-Junior; Frank Alexis; Verônica Morandi; Christina Barja-Fidalgo; Ralph Santos-Oliveira
Journal:  Int J Mol Sci       Date:  2019-12-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.